Abstract:Objective
Pregnancy is accompanied by dramatic physiologic changes in maternal plasma proteins. Characterization of the maternal plasma proteome in normal pregnancy is an essential step for understanding changes to predict pregnancy outcome. The objective of this study was to describe maternal plasma proteins that change in abundance with advancing gestational age, and determine biological processes that are perturbed in normal pregnancy.
Materials and methods
A longitudinal study included 43 normal pregnanc… Show more
“…However, 5 of the 8 placenta-specific proteins (placental growth factor, urokinase-type plasminogen activator, inhibin b A chain/activin A, MMP-12, and glypican 3) that showed significant changes across gestation in the current study paralleled the gestational changes reported by the previous study, although the latter 2 did not show significant changes after adjusting for multiple testing in our data set. The sixth protein (growth differentiation factor 15) was not part of the SOMAscan platform used by Romero and coworkers (47). For the 26 remaining proteins, the results from the 2 studies were in complete agreement.…”
Section: Discussionmentioning
confidence: 86%
“…Changes across gestation in the maternal concentrations of a placentaderived protein are not critical for its usefulness as a biomarker or read-out of placental function; however, the pattern of change must be known because prediction models must allow for these changes. Romero and coworkers (47) used the SomaLogics platform to study maternal plasma proteomic profiles across gestation, and documented that there are marked gestational changes in Figure 2. Protein-protein interactions among proteins secreted by the placenta into the maternal circulation, analyzed with NetworkAnalyst.…”
We sought to identify proteins secreted by the human placenta into the maternal and fetal circulations. Blood samples from the maternal radial artery and uterine vein and umbilical artery and vein were obtained during cesarean section in 35 healthy women with term pregnancy. Slow off‐rate modified aptamer (SOMA) protein–binding technology was used to quantify 1310 known proteins. The uteroplacental and umbilical venoarterial concentration differences were calculated. Thirty‐four proteins were significantly secreted by the placenta into the maternal circulation, including placental growth factor, growth/differentiation factor 15, and matrix metalloproteinase 12. There were 341 proteins significantly secreted by the placenta into the fetal circulation. Only 7 proteins were secreted into both the fetal and maternal circulations, suggesting a distinct directionality in placental protein release. We examined changes across gestation in the proteins found to be significantly secreted by the placenta into the maternal circulation using serial blood samples from healthy women. Among the 34 proteins secreted into the maternal circulation, 8 changed significantly across gestation. The identified profiles of secreted placental proteins will allow us to identify novel minimally invasive biomarkers for human placental function across gestation and discover previously unknown proteins secreted by the human placenta that regulate maternal physiology and fetal development.—Michelsen, T. M., Henriksen, T., Reinhold, D., Powell, T. L., Jansson, T. The human placental proteome secreted into the maternal and fetal circulations in normal pregnancy based on 4‐vessel sampling. FASEB J. 33, 2944–2956 (2019). http://www.fasebj.org
“…However, 5 of the 8 placenta-specific proteins (placental growth factor, urokinase-type plasminogen activator, inhibin b A chain/activin A, MMP-12, and glypican 3) that showed significant changes across gestation in the current study paralleled the gestational changes reported by the previous study, although the latter 2 did not show significant changes after adjusting for multiple testing in our data set. The sixth protein (growth differentiation factor 15) was not part of the SOMAscan platform used by Romero and coworkers (47). For the 26 remaining proteins, the results from the 2 studies were in complete agreement.…”
Section: Discussionmentioning
confidence: 86%
“…Changes across gestation in the maternal concentrations of a placentaderived protein are not critical for its usefulness as a biomarker or read-out of placental function; however, the pattern of change must be known because prediction models must allow for these changes. Romero and coworkers (47) used the SomaLogics platform to study maternal plasma proteomic profiles across gestation, and documented that there are marked gestational changes in Figure 2. Protein-protein interactions among proteins secreted by the placenta into the maternal circulation, analyzed with NetworkAnalyst.…”
We sought to identify proteins secreted by the human placenta into the maternal and fetal circulations. Blood samples from the maternal radial artery and uterine vein and umbilical artery and vein were obtained during cesarean section in 35 healthy women with term pregnancy. Slow off‐rate modified aptamer (SOMA) protein–binding technology was used to quantify 1310 known proteins. The uteroplacental and umbilical venoarterial concentration differences were calculated. Thirty‐four proteins were significantly secreted by the placenta into the maternal circulation, including placental growth factor, growth/differentiation factor 15, and matrix metalloproteinase 12. There were 341 proteins significantly secreted by the placenta into the fetal circulation. Only 7 proteins were secreted into both the fetal and maternal circulations, suggesting a distinct directionality in placental protein release. We examined changes across gestation in the proteins found to be significantly secreted by the placenta into the maternal circulation using serial blood samples from healthy women. Among the 34 proteins secreted into the maternal circulation, 8 changed significantly across gestation. The identified profiles of secreted placental proteins will allow us to identify novel minimally invasive biomarkers for human placental function across gestation and discover previously unknown proteins secreted by the human placenta that regulate maternal physiology and fetal development.—Michelsen, T. M., Henriksen, T., Reinhold, D., Powell, T. L., Jansson, T. The human placental proteome secreted into the maternal and fetal circulations in normal pregnancy based on 4‐vessel sampling. FASEB J. 33, 2944–2956 (2019). http://www.fasebj.org
“…As described above, nearly every aspect of maternal physiology is impacted by pregnancy, leading to major changes in expression and function of genes, proteins, and organ systems. In the past, many of these changes have been studied in isolation, based on available technological capabilities . However, advanced technology now enables high‐dimensional study of genes, proteins, and other analytes.…”
Section: Expanding Systems Pharmacology In Pregnancy Beyond Pbpkmentioning
confidence: 99%
“…Romero et al . recently conducted a proteomics study that sampled plasma at 3–6 time points across gestation from 43 women with normal deliveries.…”
Section: Expanding Systems Pharmacology In Pregnancy Beyond Pbpkmentioning
confidence: 99%
“…Many of these proteins are involved in angiogenesis, embryogenesis, and immune regulation. Protein‐protein interaction network mappings and functional analyses identified the proteins with the greatest change across gestation involved in general defense response; defense response to bacteria and fungi; germ cell migration; proteolysis; and leukocyte migration …”
Section: Expanding Systems Pharmacology In Pregnancy Beyond Pbpkmentioning
Pregnancy involves rapid physiological adaptation and complex interplay between mother and fetus. New analytic technologies provide large amounts of genomic, proteomic, and metabolomics data. The integration of these data through bioinformatics, statistical, and systems pharmacology techniques can improve our understanding of the mechanisms of normal maternal physiologic changes and fetal development. New insights into the mechanisms of pregnancy‐related disorders, such as preterm birth (PTB), may lead to the development of new therapeutic interventions and novel biomarkers.
This diagnostic/prognostic study describes the use of cell-free transcriptomics, urine metabolomics, and plasma proteomics for identifying the biological measurements associated with preterm birth.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.